Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 12—December 2026
Dispatch
Mayaro Virus Emergence and Genetic Dynamics, Peru
Table
Clinical manifestations and results of NGS and qRT-PCR for detected cases of Mayaro virus infection, Peru*
| Sample ID | Health facility | NGS, % coverage | qRT-PCR, Ct value | Patient age, y/sex | Clinical data |
|---|---|---|---|---|---|
| APDC040024 | Zungarococha | NA | 28.81 | 16/M | History of fever and chills, malaise, headache, fatigue, loss of appetite, back pain, abdominal pain, joint pain, nonproductive cough, nausea and vomiting, runny nose |
| APDC070024 | San Lorenzo Health Post | 64 | 29.20 | 19/F | Malaise, abdominal pain |
| APDC070034 | San Lorenzo Health Post | 78 | 29.53 | 68/M | History of fever and chills, malaise, headache, joint pain. |
| APDC070108 | San Lorenzo Health Post | 13 | 28.61 | 15/M | History of fever and chills, malaise |
| APDC010152 | Hospital de Apoyo de Iquitos | 29 | 24.67 | 31/F | History of fever and chills, headache, loss of appetite, joint pain, nausea and vomiting |
| APDC060121 | Bellavista Nanay | 100 | 24.43 | 17/F | Malaise, loss of appetite, back pain, abdominal pain, joint pain, generalized weakness and paralysis |
*Interval of collection for all samples was February–June 2024. Ct, cycle threshold; NA, not available; NGS, next-generation sequencing; qRT-PCR, quantitative reverse transcription PCR.
Page created: September 05, 2026
Page updated: October 27, 2026
Page reviewed: October 27, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.